GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Long Term Provisions | - | - | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | 0 | |
Mar2020 | - | - |
Compare Long Term Provisions of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,106.1 Cr | 6.2% | 7.5% | 110.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 6.2% |
7.5% |
110.5% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses